Dimethylnitrosamine (DMN) exposed rats: Vernonia amygdalina pre-treatment enhances immunity, hepatic and renal function

  • Authors

    • Usunomena Usunobun benson idahosa university, benin city, edo state, nigeria
    • Ngozi Okolie University of Benin
    2016-02-24
    https://doi.org/10.14419/ijbr.v4i1.5811
  • Dimethylnitrosamine, Hematology, Kidney, Liver, Vernonia amygdalina.

  • Background: The occurrence of dietary and environmental chemicals such as dimethylnitrosamine (DMN) in drinks and foods including fish and meat as well as fresh supermarket products is well established. This study evaluated protective effect of ethanolic leaf extract of Vernonia amygdalina (VAE) on liver synthetic molecules, kidney function and hematological parameters in acute dimethylnitrosamine (DMN)-induced hepatic toxicity in wistar male rats.

    Methods: Experimental rats divided into four groups of six rats each were used. The first group was untreated and served as control. The second group was orally administered VAE (400 mg/kg) only for seven days. The third group was pre-treated with VAE (400mg/kg) for 7 days and administered 20mg/kg DMN 24hrs after VAE pre-treatment. Rats of the fourth group were given 20mg/kg DMN alone same time with that of group 3. All rats were sacrificed 48hrs after DMN administration.

    Results: In rats administered 20mg/kg DMN, VAE pre-treatment at 400 mg/kg significantly increased total protein, albumin,White blood cell (WBC), Red blood cell (RBC), Hemoglobin (Hb), packed cell volume (PCV) and Platelets while it significantly decreased total bilirubin, urea and creatinine compared to DMN-alone administered rats.

    Conclusion: This study suggest that VAE pre-treatment exert its ameliorative effect against DMN-induced hematological and biochemical alterations possibly by preventing the decline of antioxidant defense system and could be prescribed as adjunct to dietary therapy.

  • References

    1. [1] Abosi AO & Raseroka BH. (2003). In vivo antimalarial activity of Vernonia amygdalina. British Journal of Biomedical Science 60(2), 89-91.

      [2] Chowdhury JR, Wolkoff AW, Arias IM, (1989) in: Scriver CR, Beaudet AL, Sly WS, Valle D, (Eds.), The Metabolic Basis ofInherited Diseases, McGraw Hill, New York, pp. 1367-1408.

      [3] Ekam VS, Johnson JT, Dasofunjo K, Odey MO. & Anyahara SE. (2012). Total protein, albumin and globulin levels following the administration of activity directed fractions of Vernonia amygdalina during acetaminophen induced hepatotoxicity in wistar rats. Annals of Biological Research 3(12), 5590-5594

      [4] Erasto P, Griersoon DS, &Afolayan AJ (2006). Bioactive sesquiterpene lactones from the leaves of Vernonia amygdalina. Journal of Ethnopharmacology 106, 117-120.http://dx.doi.org/10.1016/j.jep.2005.12.016.

      [5] George J, Rao KR, Stern R, & Chandrakasan G. (2001). Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen. Toxicology156(2-3), 129-138.http://dx.doi.org/10.1016/S0300-483X(00)00352-8.

      [6] Guengerich FP, Kim DH & Iwasaki M. (1991). Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chemical Research and Toxicology 4(2), 168-179.http://dx.doi.org/10.1021/tx00020a008.

      [7] Hashimoto M,Kothary PC. &Raper SE. (1999). Phenobarbital in comparison with carbon tetrachloride and phenobarbital-induced cirrhosis in rat liver regeneration. Journal of Surgical Research 81(2), 164–169. http://dx.doi.org/10.1006/jsre.1998.5424.

      [8] Igile GO, Oleszek W, Jurzysta M, Burda S, Fafunso M, & Fasanmade AA (1994). Flavonoids from Vernonia amygdalina and their antioxidant activities. Journal of Agriculture and Food Chemistry 42, 2445-2448.http://dx.doi.org/10.1021/jf00047a015.

      [9] Ismail RSA, El-Megeid AAA & Abdel-Moemin AR. (2009). Carbon tetrachloride-induced liver disease in rats: the potential effect of supplement oils with vitamins E and C on the nutritional status,â€German Medical Science 7, 1–10.

      [10] Izevbige EB, Bryant TL & Walker A. (2004). A novel natural hibitor of extracellular signal regulated kinases and human breast cancer cell growth. Experimental Biology and Medicine 229(2), 163-169.

      [11] Jisaka M, Ohigashi H, Takagaki T, Nozaki H, Tada T, Hirota M, Irie R, Huffman MA, Nishida T, Kaji M, & Koshimizu K (1992). Bitter steroid glucosides, Vernoniosides A1, A2 and A3 and realted B1 from a possible medicinal plant, Vernonia amygdalina, used by wild chimpanzees. Tetrahedron 48, 625-632.http://dx.doi.org/10.1016/S0040-4020(01)88123-0.

      [12] Muthulingam M. (2002). Studies on the curative efficacy of Astercanthalongifoliaon carbon tetrachloride induced hepatotoxicity in rats. Ph.D.Thesis, Annamalai University.

      [13] Peter T. Jr. (1996). All about Albumin, Biochemistry, Genetics, and Medical Applications, Academic Press, San Diego.

      [14] Teufelhofer O, Parzefall W, Kainzbauer E, Ferk F, Freiler C, Knasmuller S, Elbling L, Thurman R & Schulte-Hermann R. (2005). Superoxide generation from Kupffer cells contributes to hepatocarcinogenesis: Studies on NADPH oxidase knockout mice. Carcinogenesis 26, 319-329.http://dx.doi.org/10.1093/carcin/bgh320.

      [15] Usunobun U. (2014). Antihepatotoxic efficacy of Vernonia amygdalinaethanolic leaf extract on Dimethylnitrosamine (DMN)-induced liver damage in rats. International Journal of Healthcare and Biomedical Research 03(01), 89-98

      [16] Usunobun U. & Okolie NP (2015). Phytochemical, trace and mineral composition of Vernonia amygdalina leaves. International Journal of Biological and Pharmaceutical Research 6(5), 393-399.

      [17] Usunobun U, Okolie P.N, &Eze GI (2015). Effect of Vernonia amygdalina on some biochemical indices in Dimethylnitrosamine (DMN) induced liver injury in rats. International Journal of Animal Biology 1(4), 99-105.

      [18] Vogel AI. (1971). A textbook of practical organic Chemistry including qualitative organic analysis. Longman group limited, London. Pp 426.

      [19] Yakubu MT, Bilbis LS, Lawal M, & Akanji M.A (2003). Evaluation of selected parameters of rat liver and kidney function following repeated administration of yohimbine. Biokemistri 15, 50-56.

      [20] Zilva JF, Panmall PR, & Mayne PD (1991). Clinical Chemistry in Diagnosis and Treatment. 5th Edition. England Clays Ltd, St. Ives Plc, England.

  • Downloads

  • How to Cite

    Usunobun, U., & Okolie, N. (2016). Dimethylnitrosamine (DMN) exposed rats: Vernonia amygdalina pre-treatment enhances immunity, hepatic and renal function. International Journal of Biological Research, 4(1), 17-20. https://doi.org/10.14419/ijbr.v4i1.5811